Spansion challenges Macronix patent claims Spansion has filed petitions with the USPTO's Patent Trial and Appeal Board to invalidate the patents that are being asserted against Spansion by Macronix International and Macronix America in an investigation that is currently pending at the U.S. International Trade Commission. In its petitions, Spansion challenges the validity of three patents addressing technologies directed to circuit designs and circuit layouts. The PTAB's decision on granting these petitions is expected in early 2015.
Cypress Semiconductor price target raised to $18 from $13 at Sterne Agee Sterne Agee increased its price target on Cypress (CY) as the firm expects the company's merger with Spansion (CODE) to produce about $135M of synergies, with 50% of the synergies materializing in the first year. The firm keeps a Buy rating on Cypress.